I graduated in 2016 with a MSc in Biomedical Sciences after a 7-month research internship at the i3s institute in Porto. There, I have tried to implement two techniques to enhance and facilitate drug target identification and drug development in Leishmania. On the one hand, I performed targeted mutagenesis with CRISPR-Cas9 and on the other hand, I implemented a red-shifted luciferase in Leishmania to facilitate in vivo imaging in deeper tissues. Currently, I am a PhD candidate at the Laboratory of Medical and Molecular Oncology in the field of pancreatic cancer at the Vrije Universiteit Brussel, Oncology Research Centre under the supervision of Prof. Dr. Ilse Rooman.
I3S is a transdisciplinary institution committed to promoting research and innovation in the Health Sciences at the highest international level while carrying out graduate training and contributing to solving current major societal challenges. Over a thousand people work at i3S, which is organized into three thematic units: Cancer; Infection, Immunity & Regeneration; and Neurobiology & Neurologic Disorders. At i3S we capitalize on the institute’s scientific know-how by translating it into valuable assets for society, thus playing a crucial role in the development of a sustainable and solid regional strategy.
In Vivo Imaging
We found 1 Elyne Backx's email addresses
Elyne Backx's social media include: Linkedin,
Elyne Backx works for CellCarta
Elyne Backx's role in CellCarta is Histoscientist | Application Owner
Elyne Backx's latest job experience is Histoscientist | Application Owner at CellCarta
Elyne Backx's latest education in Vrije Universiteit Brussel
Elyne Backx holds 8.1 years of experience, with a skill set including Molecular Biology, currently in the role of Histoscientist | Application Owner at CellCarta. Based in Antwerp, Flemish Region, Belgium, reach out via LinkedIn at https://www.linkedin.com/in/elyne-backx-4b0a8953. Earlier roles at [object Object]. Part of a 746-strong workforce, contributing to the Biotechnology Research market.